2020
DOI: 10.1007/s00702-020-02266-z
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum toxin therapy of dystonia

Abstract: Botulinum toxin (BT) is used to treat a large number of muscle hyperactivity syndromes. Its use in dystonia, however, is still one of the most important indications for BT therapy. When BT is injected into dystonic muscles, it produces a peripheral paresis which is localised, well controllable and follows a distinct and predictable time course of around 3 months. Adverse effects are always transient and usually mild, long-term application is safe. With this profile BT can be used to treat cranial dystonia, cer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
19
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(21 citation statements)
references
References 31 publications
(23 reference statements)
0
19
0
2
Order By: Relevance
“…4 weeks after application and slowly wears off as the neuromuscular junction recovers within 12 weeks [ 2 , 3 ]. Thanks to the long-lasting effect and good safety profile, intramuscular injections of BoNT-A have become the first-line treatment for focal spasticity [ 4 , 5 , 6 ] and dystonia [ 7 ]. Although, in general, clinical improvement usually follows the time course of the peripheral changes, there are a number of reports of discrepancies between the clinical symptoms and the duration or degree of neuromuscular junction blockade [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…4 weeks after application and slowly wears off as the neuromuscular junction recovers within 12 weeks [ 2 , 3 ]. Thanks to the long-lasting effect and good safety profile, intramuscular injections of BoNT-A have become the first-line treatment for focal spasticity [ 4 , 5 , 6 ] and dystonia [ 7 ]. Although, in general, clinical improvement usually follows the time course of the peripheral changes, there are a number of reports of discrepancies between the clinical symptoms and the duration or degree of neuromuscular junction blockade [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Doses range between 20-40 MU of ONA are used. 4 Focal dystonia is a common, invalidating neurologic condition characterized by involuntary, sustained muscle contractions causing twisting movements and abnormal postures in one body part. Local injections with Botulinum toxin A (BTX A) are safe and effective in the treatment of focal dystonia.…”
Section: Dystoniamentioning
confidence: 99%
“…3. Group III -can produce toxins C or D. 4. Group IV -can produce toxin G (does not cause neuroparalytic illness).…”
Section: Introductionmentioning
confidence: 99%
“…Since CD is a long-term disease, it requires long-term treatment [ 7 ]. Repetitive intramuscular injections of botulinum toxin (BoNT) every 10 to 16 weeks have become treatment of choice for this chronic neurological disorder [ 3 , 7 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%